Ditiocarb sodium,98%

Ditiocarb sodium,98% (Sodium diethyldithiocarbamate,98%) is an orally active copper reagent. Ditiocarb sodium,98% exhibits activities such as antioxidation, chelation, anti-tumor effects, immunomodulation, and anti-HIV properties. Ditiocarb sodium,98% can be used in the research of tumors, inflammatory, and immune-related diseases[1][2][3][4].

Product Specifications

CAS Number

[148-18-5]

Product Name Alternative

Sodium diethyldithiocarbamate,98%

UNSPSC

12352211

Hazard Statement

H315, H319, H335

Target

Biochemical Assay Reagents; HIV

Type

Reference compound

Related Pathways

Anti-infection; Others

Field of Research

Cancer; Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/sodium-diethyldithiocarbamate-98.html

Purity

99.2

Solubility

DMSO : 50 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)

Smiles

S=C(S[Na])N(CC)CC

Molecular Formula

C5H10NNaS2

Molecular Weight

171.26

Precautions

H315, H319, H335

References & Citations

[1]Abeer A.El-Saharty, et al. Sodium diethyldithiocarbamate as accelerator of the rate of copper cementation. The Egyptian Journal of Aquatic Research. 2015 Dec, Volume 41 (4) :289-293.|[2]Hersh EM, et al. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. JAMA. 1991 Mar 27;265 (12) :1538-44. |[3]Borch RF, et al. Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model. Proc Natl Acad Sci U S A. 1979 Dec;76 (12) :6611-4.|[4]Perchellet JP, et al. Inhibition of multistage tumor promotion in mouse skin by diethyldithiocarbamate. Cancer Res. 1987 Dec 1;47 (23) :6302-9.